Results 271 to 280 of about 51,709 (292)

The development of a method to measure [3H] dopamine uptake by washed platelets provides no evidence for circulating inhibitors of platelet dopamine uptake in schizophrenia

Biological Psychiatry, 1994
Altered [3H] dopamine uptake by platelet-rich plasma (PRP) has been reported in some subjects with schizophrenia (Rotman et al 1980; Dean et al 1990). As platelet dopamine uptake was measured using PRP, it was not possible to determine if the changes in schizophrenia were intrinsic to the platelet or due to plasma factors.
S, Sundram, B, Dean, D L, Copolov
openaire   +2 more sources

Neostriatal Dopamine Uptake and Reversal of Age‐related Movement Disorders with Dopamine‐Uptake Inhibitorsa

Annals of the New York Academy of Sciences, 1988
C A, Altar, J F, Marshall
openaire   +2 more sources

Central antisecretory and peripheral gastroprotective effects of GBR 12909, a selective dopamine uptake inhibitor

Life Sciences, 1994
A variety of dopaminergic compounds influence gastric secretion and response to injury. In particular, agonists of the D1 receptor are gastroprotective when given either centrally of peripherally. In the present studies, we show that an indirect dopamine (DA) promoter, GBR 12909, a selective DA uptake inhibitor given ip but not icv, protects against ...
openaire   +2 more sources

Antipsychotics/dopamine-uptake-inhibitors/serotonin-uptake-inhibitors

Reactions Weekly, 2020
openaire   +1 more source

Pharmacological profile of PR-000608, a novel dopamine uptake inhibitor

European Neuropsychopharmacology, 1996
M. Inazu, M. Harada, N. Kubota, T. Masuda   +3 more
openaire   +1 more source

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial

Lancet, The, 2014
Richard G Gray, Natalie Ives, Alastair Gray   +2 more
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Peripherally-restricted dopamine agonist but not norepinephrine uptake inhibitor alters prolactin release

Journal of Pharmacological and Toxicological Methods, 2012
Lewis B. Kinter, Jen Venzie, Pam Campbell, Patricia Bentley, Hakan Andersson, Jane Stewart, Russell Huby, David A. Brott   +7 more
openaire   +1 more source

Supraspinal effects of dopamine uptake inhibitor on the micturition reflex in rats

European Urology Supplements, 2017
M. Honda, N. Yoshimura, Y. Kimura, B. Kawamoto, P. Tsounapi, K. Hikita, S. Shimizu, T. Shimizu, M. Saito, M. Chancellor, A. Takenaka   +10 more
openaire   +1 more source

Pharmacological effects of GYMI 52 895, a new selective dopamine uptake Inhibitor

European Journal of Pharmacology, 1990
K. Horváth, H. Szabó, M. Pátfalusi, P. Berzsenyi, F. Andrási   +4 more
openaire   +1 more source